Cargando…

CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma

Drug resistance is a significant obstacle in cancer treatment and therefore a frequent subject of research. Developed or primary resistance limits the treatment success of inhibitors of the B cell receptor (BCR) pathway in mantle cell lymphoma (MCL) patients. Recent research has highlighted the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rauert-Wunderlich, Hilka, Rudelius, Martina, Berberich, Ingolf, Rosenwald, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833745/ https://www.ncbi.nlm.nih.gov/pubmed/29367645 http://dx.doi.org/10.1038/s41419-017-0157-6

Ejemplares similares

Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
por: Rudelius, Martina, et al.
Publicado: (2018)

CD52 and OXPHOS—potential targets in ibrutinib-treated mantle cell lymphoma
por: Fuhr, Viktoria, et al.
Publicado: (2022)

The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NFκB Transcription Factors
por: Rauert-Wunderlich, Hilka, et al.
Publicado: (2013)

Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series
por: Zamò, Alberto, et al.
Publicado: (2022)

Time-Resolved scRNA-Seq Tracks the Adaptation of a Sensitive MCL Cell Line to Ibrutinib Treatment
por: Fuhr, Viktoria, et al.
Publicado: (2021)

NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
por: Balaji, Swathi, et al.
Publicado: (2018)

REGγ promotes mantle cell lymphoma cell apoptosis by downregulating NF-κB signaling
por: Zeng, Xin-Xin, et al.
Publicado: (2023)

CD40-Mediated Activation of the NF-κB2 Pathway
por: Hostager, Bruce S., et al.
Publicado: (2013)

CD40L Priming of Platelets via NF‐κB Activation is CD40‐ and TAK1‐Dependent
por: Kojok, Kevin, et al.
Publicado: (2018)

The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1(+) subgroup of multiple myeloma cells for TNF-induced cell death
por: El-Mesery, Mohamed, et al.
Publicado: (2019)

A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
por: Chen, Jingtao, et al.
Publicado: (2015)

Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma
por: Enjuanes, Anna, et al.
Publicado: (2011)

Aberrant CD40-Induced NF-κB Activation in Human Lupus B Lymphocytes
por: Zhang, Wen, et al.
Publicado: (2012)

The riddle of lymphoma BCR-antigenes
por: Thurner, Lorenz, et al.
Publicado: (2018)

Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
por: Yang, David T, et al.
Publicado: (2008)

Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody
por: Li, Ziduo, et al.
Publicado: (2020)

CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
por: Freile, Jimena Álvarez, et al.
Publicado: (2022)

CD40 Signaling Synergizes with TLR-2 in the BCR Independent Activation of Resting B Cells
por: Jain, Shweta, et al.
Publicado: (2011)

Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017)

Characterizing the role of the alternative NF-κB pathway in diffuse large B-cell lymphoma
por: Ito, Daisuke, et al.
Publicado: (2013)

Alternative end-joining in BCR gene rearrangements and translocations: Alternative end-joining in BCR gene rearrangements and translocations
por: Bai, Wanyu, et al.
Publicado: (2022)

Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma
por: Chiron, David, et al.
Publicado: (2015)

The Synthetic Compound Norcantharidin Induced Apoptosis in Mantle Cell Lymphoma In Vivo and In Vitro through the PI3K-Akt-NF-κB Signaling Pathway
por: Lv, Hongyan, et al.
Publicado: (2013)

High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis
por: Li, Philippa, et al.
Publicado: (2021)

CIN85 drives B cell responses by linking BCR signals to the canonical NF-κB pathway
por: Kometani, Kohei, et al.
Publicado: (2011)

NF-κB Suppresses ROS Levels in BCR-ABL+ Cells to Prevent Activation of JNK and Cell Death
por: Stein, Sarah J., et al.
Publicado: (2011)

Mantle cell lymphoma with features of marginal-zone lymphoma
por: Randen, Ulla, et al.
Publicado: (2011)

Primary gastric mantle cell lymphoma
por: Petranovic, Duska, et al.
Publicado: (2012)

Mantle cell lymphoma with skin involvement
por: Kalińska-Bienias, Agnieszka, et al.
Publicado: (2015)

Esophageal location of mantle cell lymphoma
por: Michopoulos, Spyros
Publicado: (2016)

Tracheobronchial involvement of mantle cell lymphoma
por: Tong, Lin, et al.
Publicado: (2018)

Mantle Cell Lymphoma Case Report
por: Podzolkov, V.I., et al.
Publicado: (2018)

Educational Case: Mantle Cell Lymphoma
por: Mai, Brenda, et al.
Publicado: (2020)

Emerging therapies in mantle cell lymphoma
por: Hanel, Walter, et al.
Publicado: (2020)

Tackling Mantle Cell Lymphoma in Europe
por: Horgan, Denis, et al.
Publicado: (2022)

Modulation of B cell activation threshold mediated by BCR/CD40 costimulation by targeting Cbl-b for ubiquitination
por: Tang, Na, et al.
Publicado: (2019)

CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases
por: Xu, Jie, et al.
Publicado: (2017)

Smudge cells in CD200(+), TP53 mutated leukemic mantle cell lymphoma
por: Jain, Preetesh, et al.
Publicado: (2022)

Cutaneous Involvement as a First Sign of CD5(-) Blastoid Mantle Cell Lymphoma
por: Zekey, Emre, et al.
Publicado: (2023)

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
por: Morello, Lucia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9o1d8fnnrs6614upimj9vqtrnp